Pimecrolimus for the treatment of vulvar lichen sclerosus: A report of 4 cases

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 49, Issue 10, 2004, Pages 778-780

  Goldstein, Andrew T ^a   Marinoff, Stanley C ^a   Christopher, Kurt ^a  

^a NONE

Author keywords

Lichen sclerosus; Pimecrolimus; Vulvar diseases

Indexed keywords

PIMECROLIMUS;

ADULT; BURNING SENSATION; CLINICAL FEATURE; CONFERENCE PAPER; CREAM; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LICHEN SCLEROSUS ET ATROPHICUS; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; SKIN BIOPSY; VULVA DISEASE; VULVA PRURITUS;

EID: 7244231527     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Lubach D, Rath J, Kietzmann M: Steroid-induced dermal thinning: Discontinuous application of clobetasol-17-propionate ointment. Dermatology 1992;185:44-48
2. Lukowsky A, Muche JM, Sterry W, et al: Detection of expanded T cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T cell receptor-gamma polymerase chain reaction assays. J Invest Dermatol 2000;115:254-259
3. Assmann T, Becker-Wegerich P, Grewe M, et al: Tacrolimus ointment for the treatment of vulvar lichen sclerosus. J Am Acad Dermatol 2003;48:935-937
4. Bohm M, Frieling U, Luger TA, et al: Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Arch Dermatol 2003;139:922-924
5. Kunstfeld R, Kirnbauer R, Stingl G, et al: Successful treatment of vulvar lichen sclerosus with topical tacrolimus. Arch Dermatol 2003;139:850-852
6. Bracco GL, Carli P, Sonni L, et al: Clinical and histologic effects of topical treatments of vulval lichen sclerosus: A critical evaluation. J Reprod Med 1993;38:37-40
7. Virgili A, Corazza M, Bianchi A, et al: Open study of topical 0.025% tretinoin in the treatment of vulvar lichen sclerosus: One year of therapy. J Reprod Med 1995;40:614-618
8. Wakelin SH, James MP: Extensive lichen sclerosus et atrophicus with bullae and ulceration: Improvement with hydroxychloroquine. Clin Exp Dermatol 1994;19:332-334
9. Bornstein J, Heifetz S, Kellner Y, et al: Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus. Am J Obstet Gynecol 1998;178:80-84
10. Dalziel KL, Millard PR, Wojnarowska F: The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol propionate 0.05%) cream. Br J Dermatol 1991;124:461-464
11. Dalziel KL, Wojnarowska F: Long-term control of vulval lichen sclerosus after treatment with a potent topical steroid cream. J Reprod Med 1993;38:25-27
12. Pierard GE, Pierard-Franchimont C, Ben Mosbah T, et al: Adverse effects of topical corticosteroids. Acta Derm Venereol (Stockh) (suppl) 1989;151:26-30; discussion 47-52
13. Cherian MP, AbdulJabbar M: Cushing's syndrome and adrenal suppression from percutaneous absorption of clobetasol propionate in infants. Saudi Med J 2001;22:1139-1141
14. Eichenfield LF, Beck L: Elidel (pimecrolimus) cream 1%: A nonsteroidal topical agent for the treatment of atopic dermatitis. J Allergy Clin Immunol 2003;111:1153-1168
15. Amstey MS: Erosive lichen planus of the vulva and vagina. Obstet Gynecol 2003;102:645
16. Kirtschig G, Van Der Meulen AJ, Ion Lipan JW, et al: Successful treatment of erosive vulvovaginal lichen planus with topical tacrolimus. Br J Dermatol 2002;147:625-626
17. Gupta AK, Chow M: Pimecrolimus: A review. J Eur Acad Dermatol Venereol 2003;17:493-503
18. Reitamo S, Rissanen J, Remitz A, et al: Tacrolimus ointment does not affect collagen synthesis: Results of a single-center randomized trial. J Invest Dermatol 1998;111:396-398
19. Ruzicka T, Bieber T, Schopf E, et al: A short-term trial of tacrolimus ointment for atopic dermatitis: European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 1997;337:816-821
20. Ridley CM: Genital lichen sclerosus (lichen sclerosus et atrophicus) in childhood and adolescence. J R Soc Med 1993;86:69-75